Snake Venom Proteins Modulating the Interaction between von Willebrand Factor and Platelet Glycoprotein lb

Yoshihiro Fujimura; Tomihisa Kawasaki; Koiti Titani

doi:10.1055/s-0038-1650636

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1996; 76(05): 633-639
DOI: 10.1055/s-0038-1650636

Review Article

Schattauer GmbH Stuttgart

Snake Venom Proteins Modulating the Interaction between von Willebrand Factor and Platelet Glycoprotein lb

Authors

Yoshihiro Fujimura

¹The Department of Blood Transfusion, Nara Medical University, Kashihara, Nara, Japan
Tomihisa Kawasaki

²Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd., Tsukuba, Ibaraki, Japan
Koiti Titani

³Institute of Comprehensive Medical Science, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Abstract

PDF Download

PDF (910 kb)

References

References
1 Girma JP, Meyer D, Verweij CL, Pannekoek H, Sixma JJ. Structure-func-tion relationship of human von Willebrand factor. Blood 1987; 70: 605-611
2 Sadler JE. von Willebrand factor. J Biol Chem 1991; 266: 18172-18178
3 Fujimura Y, Titani K. Structure and function of von Willebrand factor. In: Haemostsis and Thrombosis, 3rd edn Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Churchill Livingstone, London: 379-395 1993
4 Howard MA, Firkin BG. Ristocetin - a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh 1978; 26: 362-369
5 Read MS, Shermer RW, Brinkhous KM. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor. Proc Natl AcadSci USA 1978; 75: 4514-4518
6 Brinkhous KM, Read MS, Fricke WA, Wagner RH. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex. Proc Natl Acad Sci USA 1983; 80: 1463-1466
7 Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Heliums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988; 71: 1366-1374
8 Ikeda Y, Handa M, Kamata T, Kawano K, Kawai Y, Watanabe K, Kawa-kami K, Sakai K, Fukuyama M, Itagaki I, Yoshioka A, Ruggeri ZM. Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb Haemost 1993; 69: 496-502
9 Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, Mclntire LV. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Wille-brand factor binding to platelets. Blood 1993; 81: 1263-1276
10 Savage B, Sadlivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-297
11 Kroll MH, Harris TS, Moake JL, Handin RI, Schafer AI. von Willebrand factor binding to GPIb initiates signals for for platelet activation. J Clin Invest 1991; 88: 1568-1573
12 Ozaki Y, Satoh K, Yatomi Y, Miura S, Fujimura Y, Kume S. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein lb and von Willebrand factor. Biochem Biophys Acta 1995; 1243: 482-488
13 Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein lb. Proc Natl Acad Sci USA 1986; 261: 12579-12585
14 Titani K, Takio K, Handa M, Ruggeri ZM. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein lb. Proc Natl Acad Sci USA 1987; 84: 5610-5614
15 Lopetz JA, Chung DW, Fujikawa K, Hagen FS, Papayannopoulou T, Roth GJ. Cloning of the a chain of human platelet glycoprotein lb: A transmembrane protein with homology to leucine- rich a2- glycoprotein. Proc Natl Acad Sci USA 1987; 84: 5615-5619
16 Hess D, Schaller J, Rickli EE, Clemetson KJ. Identification to the disulphide bonds in human platelet glycocalicin. Eur J Biochem 1991; 199: 389-393
17 Cruz MA, Petersen E, Turci SM, Handin RI. Functional analysis of a recombinant glycoprotein Iba polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein lb- IX complex and to collagen. J Biol Chem 1992; 267: 1303-1309
18 Nurden AT. Human platelet membrane glycoproteins. In: Haemostasis and Thrombosis, 3rd edn Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds) Churchill Livingstone, London: 115-165 1993
19 Read MS, Potter JY, Brinkhous KM. Role of botrocetin in platelet agglutination: Formation of an activated complex of botrocetin and von Wille-brand factor. Blood 1989; 74: 1031-1035
20 Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Bemdt MC. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin- mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1989; 28: 8317-8326
21 Okumura T, Lombart C, Jamieson GA. Platelet glycocalicin II. Purification and characterization. J Biol Chem 1976; 251: 5950-5955
22 Fujimura Y, Titani K, Usami Y, Suzuki M, Oyama R, Matsui T, Fukui H, Sugimoto M, Ruggeri ZM. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry 1991; 30: 1957-1964
23 Paine MJI, Desmond HP, Theakston DG, Crampton JM. Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. J Biol Chem 1992; 267: 22869-22876
24 Usami Y, Fujimura Y, Miura S, Shima H, Yoshioka A, Hirano K, Suzuki M, Titani K. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochem Biophy Res Commun 1994; 201: 331-339
25 Usami Y, Fujimura Y, Suzuki M, Ozeki Y, Nishio K, Fukui H, Titani K. Primary structure of two-chain botrocetin; a von Willebrand factor modulator purified from the venom of Bothrops jararaca. Proc Natl Acad Sci USA 1993; 90: 928-932
26 Drickamer K. Two distinct classes of carbohydrate recognition-domains in animal lectins. J Biol Chem 1988; 263: 9557-9560
27 Giga Y, Ikai A, Takahashi K. The complete amino acid sequence of echinoidin, a lectin from the coelomic fluid of the sea urchin Anthocidaris crassispina. J Biol Chem 1987; 262: 6197-6203
28 Hirabayashi J, Kusunoki T, Kasai K. Complete primary structure of a galactose-specific lectin from the venom of the Rattlesnake Crotalus atrox. Homologies with Ca2+-dependent-type lectins. J Biol Chem 1991; 266: 2320-2326
29 Fujimura Y, Titani K, Holland LZ, Russell SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS. von Willebrand factor. A reduced and alkylated 52/48 kDa fragment beginning at amino acid residue 449 contains the domains interacting with platelet glycoprotein lb. J Biol Chem 1986; 261: 381-385
30 Fujimura Y, Usami Y, Titani K, Niinomi K, Nishio K, Takase T, Yoshioka A, Fukui H. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4 which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein lb. Blood 1991; 77: 113-120
31 Azuma H, Hayashi T, Dent JA, Ruggeri ZM, Ware J. Disulfide bond requirements for assembly of the platelet glycoprotein Ib-binding domain of von Willebrand factor. J Biol Chem 1993; 268: 2821-2827
32 Dong Z, Thomas RS, Crimmins DL, McCourt DW, Tuley EA, Sadler JE. Disulfide bonds required to assemble functional von Willebrand factor multimers. J Biol Chem 1994; 269: 6753-6758
33 Fujimura Y, Miyata S, Nishida S, Miura S, Kaneda M, Yoshioka A, Fukui H, Katayama M, Tuddenham EGD, Usami Y, Titani K. The interaction of botrocetin with normal or variant von Willebrand factor (types IIA and IIB) and its inhibition by monoclonal antibodies that block receptor binding. Thromb Haemost 1992; 68: 464-469
34 Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin: a model for regulation of von Willebrand factor binding to platelet glycoprotein lb. J Biol Chem 1991; 266: 18172-18178
35 Sugimoto M, Ricca G, Hrinda ME, Schreiber AB, Searfoss GH, Bottini E, Ruggeri ZM. Functional modulation of the isolated glycoprotein lb binding domain of von Willebrand factor expressed in Escherichia coli. Biochemistry 1991; 30: 5202-5209
36 Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Bemdt MC. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val481 - Gly-718) to the N-terminal region of the a-chain of membrane glycoprotein lb on intact platelets with bis (sulfosuc-cinimidyl) suberate. Biochemistry 1989; 28: 8326-8336
37 Miura S, Fujimura Y, Sugimoto M, Kawasaki Y, Ikeda Y, Titani K, Yoshioka A. Structural elements influencing von Willebrand factor (vWF) affinity for platelet glycoprotein lb within a dispase-digested vWF. Blood 1994; 84: 1553-1558
38 Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. Thromb Haemost 1993; 69: 177-184
39 Hilbert L, Gaucher C, de Romeuf C, Horellou MH, Mazurier C. Leu 697->-Val mutation in mature von Willebrand factor is responsible for type IIB von Willebrand disease. Blood 1994; 83: 1542-1550
40 Federici AB, Stabile MT, Canciani S, Miyata S, Ware JL. New mutation Ile(546)(Val in a family with type IIB von Willebrand disease characterized by spontaneous platelet aggregation, thrombocytopenia and normal levels of ristocetin cofactor. Thromb Haemost 1995; 73: 1170 (abstract)
41 Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA, Ruggeri ZM, Zimmerman TS. Structure of the von Willebrand factor domain interacting with glycoprotein lb. J Biol Chem 1988; 263: 17901-17904
42 Bemdt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence. Mechanisms of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992; 31: 11144-11151
43 Sobel M, Sobel DF, Kermode JC, Harris RB. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 1992; 267: 8857-8862
44 Christophe O, Obert B, Meyer D, Girma JP. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein lb, heparin, and collagen and resides between amino acid residues Leu512 and Lys673. Blood 1991; 78: 2310-2317
45 Makita K, Miura S, Shimoyama T, Narita N, Sakurai T, Sugimoto M, Yoshioka A, Titani K, Ruggeri ZM, Fujimura Y. Characterization of murine anti-botrocetin monoclonal antibodies. Int J Haematol 1995; 61: 276 (Abstract)
46 Vicente V, Houghten RA, Ruggeri ZM. Identification of a site in the alpha chain of platelet glycoprotein lb that participates in von Willebrand factor binding. J Biol Chem 1990; 265: 274-280
47 Katagiri Y, Hayashi Y, Yamamoto K, Tanoue K, Kosaki G, Yamazaki H. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein GPIb. Thromb Haemost 1990; 63: 122-126
48 Dong JF, Li CQ, Lopez JA. Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994; 33: 13946-13953
49 Marchese P, Murata M, Mazzucatto M, Pradella P, De Marco L, Ware J, Ruggeri ZM. Identification of three tyrosine residues of glycoprotein lb a with distinct roles in von Willebrand factor and a-thrombin binding. J Biol Chem 1995; 270: 9571-9578
50 Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloprotease, cleaves the platelet von Willebrand factor receptor glycoprotein lb a. Identification of the sulfated tyrosine/anionic sequence Tyr276-Glu282 of glycoprotein Iba as a binding site for von Willebrand factor and a-thrombin. Biochemistry 1996; 35: 4929-4938
51 Scarborough RM, Hsu MA, Teng W, Nannizzi L, Rose JW. Purification and characterization of potent inhibitors of von Willebrand factor binding to glycoprotein (GP)Ib from the venom of the timber rattlesnake, Crotalus h. horridus. Blood 1991; 78: 1568 (abstract)
52 Peng M, Lu W, Kirby EP. Alboaggregin-B: a new platelet agonist that binds to platelet membrane glycoprotein lb. Biochemistry 1991; 30: 11529-11536
53 Peng M, Lu W, Kirby EP. Characterization of three alboaggregins purified from Trimeresurus alborablis venom. Thromb Haemost 1992; 67: 702-707
54 Yoshida E, Fujimura Y, Miura S, Sugimoto M, Fukui H, Narita N, Usami Y, Suzuki M, Titani K. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets. Biochem Biophy Res Commun 1993; 1386-1392
55 Usami Y, Suzuki M, Yoshida E, Sakurai Y, Hirano K, Kawasaki T, Fujimura Y, Titani K. Primary structure of alboaggregin-B purified from the venom of Trimeresurus alborablis. Biochem Biophys Res Comm 1996; 219: 727-733
56 Peng M, Lu W, Beviglia L, Niewiarowski S, Kirby EP. Echicetin: a snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein lb. Blood 1993; 81: 2321-2328
57 Chen YL, Tsai IH. Functional and sequence characterization of agkicetin, a new glycoprotein lb antagonist isolated from Agkistrodon acutus venom. Biochem Biophys Res Commun 1995; 210: 472-477
58 Peng M, Holt JC, Niewiarowski S. Isolation, characterization and amino acid sequence of echicetin (3 subunit, a specific inhibitor to von Willebrand factor and thrombin interaction with glycoprotein lb. Biochem Biophys Res Commun 1994; 205: 68-72
59 Fujimura Y, Ikeda Y, Miura S, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T. Isolation and characterization of jarara-ca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein lb. Thromb Haemost 1995; 74: 743-750
60 Taniuchi Y, Kawasaki T, Fujimura Y, Suzuki M, Titani K, Sakai Y, Kaku S, Hisamichi N, Satoh N, Takenaka T, Handa M, Sawai Y. Flavocetin-A and -B, two high molecular mass glycoprotein lb binding proteins with high affinity purified from Trimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress. Biochem Biophys Acta 1995; 1244: 331-338
61 Kawasaki T, Taniuchi Y, Hisamichi N, Fujimura Y, Suzuki M, Titani K, Kaku S, Satoh N, Takenaka T, Handa M, Sawai Y. Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein lb and inhibits von Willebrand factor- dependent shear-induced platelet aggregation. Biochem J 1995; 308: 947-953
62 Kawasaki T, Fujimura Y, Usami Y, Suzuki M, Miura S, Sakurai Y, Makita K, Taniuchi Y, Hirano K, Titani K. Complete amino acid sequence and identification of the platelet glycoprotein lb binding site of jararaca GPIb-BP, a snake venom protein isolated from Bothrops jararaca. J Biol Chem 1996; 271: 10635-10639